18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic marker of imatinib-resistant gastrointestinal stromal tumors
Surgery Today · 2025
DOI: 10.1007/s00595-025-03029-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, 2025. Verfasst von Kota Kawabata und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Imatinib Mesylate, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. ttakahashi2@gesurg.med.osaka-u.ac.jp.
- Department of Surgery, Japan Community Healthcare Organization Osaka Hospital, 4-2-78, Fukushima, Fukushima-Ku, Osaka, Japan.
- Department of Surgery, Sakai City Medical Center, Ebarajicho, Nishi-Ku, Sakai, Osaka, Japan.
- Department of Surgery, NHO Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-Ku, Osaka, Japan.
Zitieren
APA
Kawabata, K., Takahashi, T., Nishida, T., Kurokawa, Y., Yamamoto, K., Saito, T., Momose, K., Yamashita, K., Tanaka, K., Makino, T., Kawabata, R., Takeno, A., Nakajima, K., Eguchi, H., & Doki, Y. (2025). 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic marker of imatinib-resistant gastrointestinal stromal tumors. Surgery Today. https://doi.org/10.1007/s00595-025-03029-7
Vancouver
Kawabata K, Takahashi T, Nishida T, Kurokawa Y, Yamamoto K, Saito T, et al. 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic marker of imatinib-resistant gastrointestinal stromal tumors. Surgery Today. 2025. doi:10.1007/s00595-025-03029-7
BibTeX
@article{Kawabata2025,
author = {Kawabata, Kota and Takahashi, Tsuyoshi and Nishida, Toshirou and Kurokawa, Yukinori and Yamamoto, Kazuyoshi and Saito, Takuro and Momose, Kota and Yamashita, Kotaro and Tanaka, Koji and Makino, Tomoki and Kawabata, Ryohei and Takeno, Atsushi and Nakajima, Kiyokazu and Eguchi, Hidetoshi and Doki, Yuichiro},
title = {18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic marker of imatinib-resistant gastrointestinal stromal tumors},
journal = {Surgery Today},
year = {2025},
doi = {10.1007/s00595-025-03029-7}
}
EUVIMED